BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 16099471)

  • 1. Kynurenine metabolism in plasma and in red blood cells in Parkinson's disease.
    Hartai Z; Klivenyi P; Janaky T; Penke B; Dux L; Vecsei L
    J Neurol Sci; 2005 Dec; 239(1):31-5. PubMed ID: 16099471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kynurenine metabolism in multiple sclerosis.
    Hartai Z; Klivenyi P; Janaky T; Penke B; Dux L; Vecsei L
    Acta Neurol Scand; 2005 Aug; 112(2):93-6. PubMed ID: 16008534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased serum and red blood cell kynurenic acid levels in Alzheimer's disease.
    Hartai Z; Juhász A; Rimanóczy A; Janáky T; Donkó T; Dux L; Penke B; Tóth GK; Janka Z; Kálmán J
    Neurochem Int; 2007 Jan; 50(2):308-13. PubMed ID: 17023091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral kynurenine metabolism in focal dystonia.
    Hartai Z; Klivenyi P; Janaky T; Penke B; Dux L; Vecsei L
    Med Chem; 2007 May; 3(3):285-8. PubMed ID: 17504201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kynurenine metabolism in Alzheimer's disease.
    Baran H; Jellinger K; Deecke L
    J Neural Transm (Vienna); 1999; 106(2):165-81. PubMed ID: 10226937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astrocytic localization of kynurenine aminotransferase II in the rat brain visualized by immunocytochemistry.
    Guidetti P; Hoffman GE; Melendez-Ferro M; Albuquerque EX; Schwarcz R
    Glia; 2007 Jan; 55(1):78-92. PubMed ID: 17024659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual effect of DL-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid.
    Luchowska E; Luchowski P; Paczek R; Ziembowicz A; Kocki T; Turski WA; Wielosz M; Lazarewicz J; Urbanska EM
    J Neurosci Res; 2005 Feb; 79(3):375-82. PubMed ID: 15605380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related increase of kynurenic acid in human cerebrospinal fluid - IgG and beta2-microglobulin changes.
    Kepplinger B; Baran H; Kainz A; Ferraz-Leite H; Newcombe J; Kalina P
    Neurosignals; 2005; 14(3):126-35. PubMed ID: 16088227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kynurenic acid metabolism in the brain of HIV-1 infected patients.
    Baran H; Hainfellner JA; Kepplinger B; Mazal PR; Schmid H; Budka H
    J Neural Transm (Vienna); 2000; 107(10):1127-38. PubMed ID: 11129102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kynurenic acid and kynurenine aminotransferase in heart.
    Baran H; Amann G; Lubec B; Lubec G
    Pediatr Res; 1997 Mar; 41(3):404-10. PubMed ID: 9078543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial aspartate aminotransferase: a third kynurenate-producing enzyme in the mammalian brain.
    Guidetti P; Amori L; Sapko MT; Okuno E; Schwarcz R
    J Neurochem; 2007 Jul; 102(1):103-11. PubMed ID: 17442055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous level of kynurenic acid and activities of kynurenine aminotransferases following transient global ischemia in the gerbil hippocampus.
    Luchowska E; Luchowski P; Sarnowska A; Wielosz M; Turski WA; Urbańska EM
    Pol J Pharmacol; 2003; 55(3):443-7. PubMed ID: 14506324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of kynurenic acid concentration in rat plasma following optically pure kynurenine administration: a comparative study between enantiomers.
    Fukushima T; Sone Y; Mitsuhashi S; Tomiya M; Toyo'oka T
    Chirality; 2009 Apr; 21(4):468-72. PubMed ID: 18655158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: Implications for Huntington's disease.
    Sapko MT; Guidetti P; Yu P; Tagle DA; Pellicciari R; Schwarcz R
    Exp Neurol; 2006 Jan; 197(1):31-40. PubMed ID: 16099455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kynurenic Acid Levels and Kynurenine Aminotransferase I, II and III Activities in Ganglia, Heart and Liver of Snail Helix Pomatia.
    Kronsteiner C; Baran H; Kepplinger B
    Cell Physiol Biochem; 2023 Aug; 57(4):279-297. PubMed ID: 37597169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 6-hydroxydopamine treatment on kynurenine aminotransferase-I (KAT-I) immunoreactivity of neurons and glial cells in the rat substantia nigra.
    Knyihár-Csillik E; Chadaide Z; Mihály A; Krisztin-Péva B; Fenyo R; Vécsei L
    Acta Neuropathol; 2006 Aug; 112(2):127-37. PubMed ID: 16788821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrolysin lowers kynurenic acid formation--an in vitro study.
    Baran H; Kepplinger B
    Eur Neuropsychopharmacol; 2009 Mar; 19(3):161-8. PubMed ID: 19008081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of kynurenic acid in human serum and its correlation with the concentration of certain amino acids.
    Fukushima T; Mitsuhashi S; Tomiya M; Iyo M; Hashimoto K; Toyo'oka T
    Clin Chim Acta; 2007 Feb; 377(1-2):174-8. PubMed ID: 17112493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Content of kynurenic acid and activity of kynurenine aminotransferases in mammalian eyes.
    Zarnowski T; Rejdak R; Zagorski Z; Juenemann AG; Zrenner E; Kocki T; Urbanska EM; Turski WA
    Ophthalmic Res; 2004; 36(2):124-8. PubMed ID: 15017110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysfunction of brain kynurenic acid metabolism in Huntington's disease: focus on kynurenine aminotransferases.
    Jauch D; Urbańska EM; Guidetti P; Bird ED; Vonsattel JP; Whetsell WO; Schwarcz R
    J Neurol Sci; 1995 May; 130(1):39-47. PubMed ID: 7650530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.